Dissolution of extemporaneous paracetamol capsules

Journal of Pharmacy Practice and Research

Volumn 34, Issue 4, 2004, Pages 276-281

  Mukhtar, Sadaf ^a   Olsen, Warren A ^a   McLachlan, Andrew J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; METHOCEL E 4M; PANAMAX; PARACETAMOL;

ABSORPTION SPECTROPHOTOMETRY; ARTICLE; DRUG CAPSULE; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SOLUBILITY; LIGHT ABSORPTION; MOLECULAR WEIGHT; POWDER; TABLET; WEIGHT;

EID: 13544260621     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr2004344276     Document Type: Article

References (25)

1. Prankerd RJ. Extemporaneous compounding. Aust J Hosp Pharm 1997; 27: 201.
2. Pappas A. Extemporaneous dispensing: opinion of Victorian community pharmacists. Aust J Hosp Pharm 1999; 29: 196-201.
3. Pappas A, Macpherson R, Stewart K. Extemporaneous prescribing: whatever happened to it? A survey of Australian general practitioners. J Pharm Pract Res 2002; 32: 310-14.
4. Gustafsson C, Bonferoni MC, Caramella C, Lennholm H, Nystrom C. Characterisation of particle properties and compaction behaviour of hydroxypropylmcthylcellulose with different degrees of methoxy/ hydroxypropyl substitution. Eur J Pharm Sci 1999; 9: 171-84.
5. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropylmethylcellulose (HPMC). Adv Drug Deliv Rev 2001; 48: 139-57.
6. Tahara K, Yamamoto K, Nishihata T. Application of model-independent and model analysis for the investigation of effect of drug solubility on its release rate from hydroxypropylmethylcellulose delayed release tablets. Int J Pharm 1996; 133: 17-27.
7. Fyfe CA, Blazek-Welsh AI. Quantitative NMR imaging of the mechanism of drug release from swelling hydroxypropylmethylcellulose tablets. J Control Release 2000; 68: 313-33.
8. Colombo P, Bettini R, Santi P, Peppas NA. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanism and optimal performance. Pharm Sci Technol Today 2000; 3: 198-204.
9. Trtt-Goe J, Pislewski N. Magnetic resonance imaging of the swelling kinetics of hydroxypropylmethylcellulose (HPMC) in water. J Control Release 2002; 80: 79-86.
10. Reynolds TD, Gehrke SH, Hussain AS, Shenouda LS. Polymer erosion and drug release characterization of hydroxypropyl methylcellulose matrices. J Pharm Sci 1998; 87: 1115-23.
11. Tahara K, Yamamoto K, Nishihata T. Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methylcellulose 2910. J Control Release 1995; 35: 59-66.
12. Cheong LW, Heng PW, Wong LF. Relationship between polymer viscosity and drug release from a matrix system. Pharm Res 1992; 9: 1510-4.
13. Bettini R, Catellani PL, Santi P, Massimo G, Peppas NA, Colombo P. Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate. J Control Release 2001; 70: 383-91.
14. Heng PW, Chan LW, Easterbrook MG, Li X. Investigation of the mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets. J Control Release 2001; 76: 39-49.
15. Vargas CI, Ghaly ES. Kinetic release of theophylline from hydrophilic swellable matrices. Drug Dev Ind Pharm 1999; 25: 1045-50.
16. Espinoza-Ramos R, Villafuerte-Robles L. Influence of admixed lactose on pelanserin hydrochloride release from hydroxpropyl methylcellulose matrix tablets. Pharm Acta Helv 1999; 74: 65-71.
17. Yang G, Li H, Zhang R, Ding D. Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets. Drug Dev Ind Pharm 2000; 26: 681-6.
18. Sako K, Sawada T, Nakashima H, Yokohama S, Sonobe T. Influence of water soluble fillers in hydroxypropylmethylcellulose matrices on in vitro and in vivo drug release. J Contol Release 2002; 81: 165-72.
19. Velasco MV, Ford JL, Rowe P, Rajabi-Siahboomi AR. Influence of drug: hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J Control Release 1999; 57: 75-85.
20. Reynolds TD, Mitchell SA, Balwinski KM. Investigation of the effect of tablet surface area/volume on the release from hydroxypropylmethylcellulose controlled-release matrix tablets. Drug Dev Ind Pharm 2002; 28: 457-66.
21. Siepmann J, Kranz H, Peppas NA, Bodmeier R. Calculation of the required size and shape of hyroxypropyl methylcellulose matrices to achieve desired drug release profiles. Int J Pharm 2000; 201: 151-64.
22. Gao P, Skoug JW, Nixon PR, Ju TR, Stemm NL, Sung KC. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release. J Pharm Sci 1996; 85: 732-40.
23. Rekhi GS, Nellore RV, Hussain AS, Tillman LG, Malinowski HJ, Augsburger LL. Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets. J Control Release 1999; 59: 327-42.
24. Sung KC, Nixon PR, Skoug JW, Ju R, Gao P, Topp EM, et al. Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets. Int J Pharm 1996; 142: 53-60.
25. Williams RO 3rd, Reynolds TD, Cabelka TD, Sykora MA, Mahaguna V. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC. Pharm Dev Technol 2002; 7: 181-93.